Lepu Biopharma Co. Ltd. Class H Financial Overview
Lepu Biopharma Co. Ltd. Class H's market cap is currently HK$9.93B. The company's EPS TTM is HK$0.0220333474; its P/E ratio is -48.49; Lepu Biopharma Co. Ltd. Class H is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
